Back to Trades
Walbert Keli
InsiderCIK 0002051489
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Walbert Keli has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $2.8M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 25 | COAG Hemab Therapeutics Holdings, Inc. | Walbert Keli | Insider | Award | $1.3M |
| Sep 25 | COAG Hemab Therapeutics Holdings, Inc. | Walbert Keli | Insider | Other | $0 |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Walbert Keli | Insider | Disposed | $876.7K |
| Jan 5 | APLS Apellis Pharmaceuticals, Inc. | Walbert Keli | Director | Grant | $368.9K |
| Dec 15 | SPRB SPRUCE BIOSCIENCES, INC. | Walbert Keli | Insider | Other | $0 |
| Dec 15 | SPRB SPRUCE BIOSCIENCES, INC. | Walbert Keli | Insider | Award | $300.6K |
6 filings